Sexually Transmitted Infections

Sexually transmitted infections (STIs) affect millions of people worldwide; approximately 1 in 5 adults in the US had an STI in 2018. More than 30 bacteria, viruses and bacteria can be transmitted through sexual contact. Many bacterial infections can be treated effectively using ceftriaxone, doxycycline, penicillin, moxifloxacin, and the nitroimidazoles for gonorrhoea, chlamydia, syphilis, Mycoplasma genitalium, and trichomoniasis, respectively, although antibiotic resistance has reduced treatment options for gonorrhoea. Viral STIs are currently incurable: hepatitis B, herpes simplex virus, HIV and human papillomavirus, though effective vaccines are available for hepatitis B and HPV, there are several vaccine candidates for HIV and herpes are in clinical development.

Expert video highlights and insights from the conference hub and comprehensive peer-reviewed articles from our journal, touchREVIEWS in Infectious Diseases, provide updates on the changing treatment landscape. To learn more about how the latest developments impact on patient outcomes view our expert-led learning activities.